Quantify will be attending ISPOR Europe 2018, November 10 – 14. You’ll find us ready to meet you at exhibitor booth #302, sharing our RWE expertise at an ISPOR Short Course, and presenting our research in poster sessions A5, G1, P1, M12. See schedule below.
Stop by our booth to learn more about Quantify’s unique services like Qfront and Tableau, our expertise in Nordic RWE, or just to chat over a cup of coffee and some sweets.
Looking forward to seeing you there!
12-14 November
Booth #302 Quantify Research
Meet some of Quantify’s RWE and modelling experts Åsa, Rosa, Fredrik, Kirk, Hanna, Julia, Emma and Anders.
Saturday 10 November
1:00 – 5:00 PM, Room 115 (P1), Short Course
Analysis of Longitudinal Data: Fixed and Random Effects Models
Kirk Geale, PhD(c). Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden and Associate Director at Quantify Research AB
Anders Gustavsson, PhD. Department of Neurobiology, Care Sciences and Society, Karolinska Institute and Partner at Quantify Research
Monday 12 November:
8:45 AM – 1:45 PM, Co-authored poster #A5
Poster Topics: CONCEPTUAL PAPERS – Health Care & Health Policy Conceptual Papers
PCP5: THE ECOLOGICAL AND SOCIAL COSTS AND BENEFITS OF INTERVENTIONS – USING THE PRODUCT CARBON FOOTPRINT IN VALUE ASSESSMENT
Co-authored by Quantify’s – Borgstrom F, Ortsater G
Tuesday 13 November:
6:00 PM – 7:00 PM, Poster Author Discussion hour #G1
Poster Topics: RESEARCH ON METHODS – Cost Methods
PRM59: DEVELOPING A MODELLING FRAMEWORK TO ASSESS THE COST-EFFECTIVENESS OF DIAGNOSTIC TESTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
Co-authored by Quantify’s – Fues Wahl H, Karlsson L, Borgström F
Wednesday 14 November:
12:15 AM – 1:15 PM, Poster Author Discussion hour #P1
Poster Topics: URINARY/KIDNEY – Cost Studies
PUK17: A COST-EFFECTIVENESS ANALYSIS OF RAASI – ENABLING PATIROMER FOR THE TREATMENT OF HYPERKALEMIA IN SWEDEN
Co-authored by Quantify’s – Widén J, Nousios P
12:15 AM – 1:15 PM, Poster Author Discussion hour #G1 and #M12
Poster Topics: MUSCULAR-SKELETAL – Cost Studies
PMS43: AN ECONOMIC VALUE FRAMEWORK TO ASSESS THE COST EFFECTIVENESS OF FRACTURE PREVENTION TREATMENTS IN PATIENTS WITH OSTEOPOROSIS AT IMMINENT RISK OF FRACTURE
Co-authored by Quantify’s – Jonsson E, Borgström F, Ström O